Pharmaceutical Filtration Market

Pharmaceutical Filtration Market by Product (Membrane, Depth filter), Systems (Single-use, Assemblies), Technique (Microfiltration, Ultrafiltration), Application (API, Vaccine, Media), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2027

Report Code: BT 4058 Mar, 2022, by marketsandmarkets.com

[417 Pages Report] The global Pharmaceutical Filtration market is projected to reach USD 29.7 billion by 2027 from USD 10.9 billion in 2022, at a CAGR of 17.0% during the forecast period of 2022 to 2027. Growth in the pharmaceutical filtration market can be attributed to factors such as the growing biopharmaceutical industry, rising R&D spending in pharmaceutical & biotechnology industries, an increasing adoption of single-use technologies, a rising number of new product launches by leading market players, increasing purity requirements in end user segments, and increasing advances in nanofiber technology. On the other hand, membrane fouling and the high capital investment required to set up new production facilities are expected to hinder market growth.

Pharmaceutical Filtration Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the Pharmaceutical Filtration Market

COVID-19 is an infectious disease caused by the recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 quickly moved from being a regional crisis to a global pandemic. The COVID-19 pandemic has increased the burden on healthcare systems across the globe. According to the World Health Organization (WHO), there were 440,807,756 confirmed cases of COVID-19 and 5,978,096 deaths as of March 4, 2022. The highest number of deaths was in the Americas, followed by Europe and Southeast Asia.

With the WHO officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical & biopharmaceutical companies have scaled up R&D and manufacturing efforts to develop and distribute test kits, vaccines, and drugs against the SARS-CoV-2 virus. The economic and social burden of the pandemic has prompted government bodies globally to increase support for vaccine development and manufacturing, which has led to an increase in the adoption of pharmaceutical filtration products for the COVID-19 research and vaccine manufacturing. Various filtration techniques are used in the development and production of vaccines. Clarification (removal of suspended matter from a fluid medium) of vaccines is a crucial step that impacts product recovery and subsequent downstream purification.

To support the downstream process (including filtration and purification) of vaccine development, biopharmaceutical firms are opting for various filtration techniques and materials. For instance, in September 2020, Merck Millipore announced that they supported Eijkman Institute for Molecular Biology (Indonesia) by donating research instruments and materials worth IDR 1.2 billion (USD 0.086 million) to expedite the process of vaccine development. Merck donated water purification systems that produce high-quality type-3 pure water with integrated reverse osmosis membranes for pretreatment and high performance. Also, the pandemic has offered growth opportunities to filtration manufacturing firms to expand their production facilities. Along similar lines, in October 2020, Sartorius announced plans to open a customer interaction center in North America to develop biopharmaceutical products. This center supported the manufacturing and development of COVID-19 vaccines. Pall Corporation, a Danaher subsidiary, offers specific filters such as syringe filters, membrane filters, air filters, and water filters for the manufacturing and R&D of vaccines and drugs.

With increasing government support, rising research activities, and the mass production of vaccines after approvals, the demand for pharmaceutical filtration products increased as they are used in the production process of vaccines and other therapeutic drugs. Overall, the impact of the coronavirus crisis on supply chains, production, and shipments to customers has been manageable in the pharmaceutical filtration market with positive organic growth. Short and medium-term predictability is extremely limited and has a negligible impact.

Global Pharmaceutical Filtration Market Dynamics

DRIVER: Increase adoption of Single use technologies

The production of biopharmaceuticals is highly regulated, with stringent sanitary and quality requirements for each stage of manufacturing. This makes manufacturing biopharmaceuticals using traditional equipment extremely complex and cost-intensive. Single-use technologies, also termed disposables, have had a transformative impact on the development and production of biopharmaceuticals. Over the last few years, biopharmaceutical manufacturers have increasingly adopted single-use technologies (SUTs) to ensure drug-pricing control to cope with economic downturns and stringent regulatory frameworks. This is evident from the data published by the BioPlan Associates in the Survey of Biopharmaceutical Manufacturing Capacity and Production, 2019. As per survey results, 85.6% of the respondents used disposable filter cartridges, 79.3% of the respondents used single-use depth filters, and 69.5% of the respondents used single use TFF devices for biopharmaceutical manufacturing at any stage of manufacturing.

Some single-use filtration systems and filter capsules & cartridges have low operating volume requirements; this allows for more flexibility in production volumes, scaled up over time, depending on the demand. For instance, GE Healthcare Life Sciences’ ReadyToProcess cartridges are designed for ultrafiltration and microfiltration and for pharmaceutical filtration applications—right from pilot to process scale. SUTs reduce the risk of cross-contamination, thereby facilitating rapid changeovers and multiple production batches. SUTs also require less space than reusable systems, less capital investment, and less sterilization. This reduces the overall operating and maintenance costs as well as the environmental impact of these operations. These products have enabled end users to achieve regulatory compliance for their processes at a cheaper cost. Thus, single-use or disposable products have proven to be a significant technological development in the pharmaceutical filtration industry, and their immense benefits have driven end-user demand and, by extension, market growth.

RESTRAINT: Issue in membrane fouling to restain market growth

Membrane filters are a huge part of the pharmaceutical filtration industry. However, irreversible membrane fouling and fiber breakage fouling are the main problems concerning membrane filters. The main issue of membrane fouling arises due to an overabundance of biological, organic, or colloidal material present in the source water, along with improper pretreatment. Conductive membranes have the potential to mitigate fouling through the induction of Rayleigh-Bιnard convection, gas evolution, electrochemical oxidation, or electrostatic repulsion of foulants. These membranes are usually prepared with conductive polymers and particles or a blend of conductive particles and a conventional polymer. The fouling can be assumed to be due to internal fouling by protein and/or external fouling by a residual.

Due to the flexibility of the fibers, these filters are more likely to break when under high strain compared to other methods of filtration such as tubular or spiral-wound elements. Membrane filters tend to have moderate capital costs but high operating costs compared to other configurations. High price and membrane fouling issues pose challenges for the greater uptake of pharmaceutical filters in biopharmaceutical filtration processes.

OPPORTUNITY: Advances in nanofiber technology to drive possibilities of Nanofiltration

Nanofiltration membranes are a relatively new technology that bridges the gap between two well-established technologies, reverse osmosis, and ultrafiltration. One of the most important characteristics of nanofiltration membranes is their ability to permeate monovalent ions, such as sodium chloride, through the membrane while rejecting divalent and multivalent ions, such as sodium sulfate. This flexibility opens up many possibilities for the use of nanofiltration in niche applications in many areas especially for water and wastewater treatment, pharmaceutical & biotechnology, and food engineering. Nanofiltration membranes have been an attractive separation process technology employed in the separation, concentration, and production of hormones & antibiotics. Also, in the blood plasma separation process, nanofiltration can be used to capture fibrinogen and other clotting compounds once blood serum and blood plasma have been separated

In the pharmaceutical industry, the newly developed nanofiber coating filtration technology offers greater flexibility, control, and durability as compared to conventional filtration methods. This new coating is made of fibers typically ranging from 0.3 to 0.5 microns in size, which can be increased to up to 1 micron. The fiber diameter distribution and layer thickness can easily be changed according to application requirements. A recent innovation is the extension of nanofiltration processes to organic solvents, which is referred to as organic solvent nanofiltration (OSN). OSN is currently an area of intensive investigation. The separation of molecules present in organic solvents by nanofiltration has great potential in industries ranging from refining to fine chemical and pharmaceutical synthesis. Thus, the advancement in nanofiber technology is expected to propel the market growth during the forecast period.

CHALLENGE: Increased cost reduced speed and yield

Sterilizing grade membrane filters are widely used for the intermediate and final filtration of liquid drug products. However, these filters have experienced rapid developments and improvements during the last decade, which have resulted in enhanced thermal and mechanical resistance. This increased efficiency has also impacted the cost of these filters, and there is a surge in the price of these products. The pharmaceutical filters undergo extensive lot release testing to ensure their performance as per standards. For sterilizing filters, manufacturers perform 100% integrity testing, along with appropriate validation tests to ensure compliance with established standards. Some larger manufacturers perform additional lot release testing to measure bacteria retention in every lot. Performing these tests in-house requires expensive equipment and specially trained scientists, which increases the cost of pharmaceutical filters.

Also, the speed of processing and preventing bottlenecks are a part of the efficiency challenge since some of the current downstream operations, such as nanofiltration, are not compatible with continuous processing. This reduces yield and increases time and efforts required creating issues for further processing.

The filters segment dominated Pharmaceutical filtration Market in 2021:

Based on products, the pharmaceutical filtration market is segmented into major three segments, namely, filters, systems, and other products. The filter market is further segmented into membrane filters, depth filters, and other filters, such as prefilters, bag filters, and magnetic filters. The systems market is further segmented into single-use systems and reusable systems. In 2021 the filters segment accounted for the largest share of the pharmaceutical market. The large share of this segment can primarily be attributed to the wide use of different types of membrane filters and depth filters for various filtration applications in the pharmaceutical industry, increased filtration requirements among the biopharmaceutical industry, and the higher frequency of purchase of these filters compared to systems and other filtration products.

Pharmaceutical Filtration Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for Pharmaceutical filtration Market in 2021.

The global pharmaceutical filtration market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the pharmaceutical filtration market, followed by Europe and the Asia Pacific. The largest share of this segment can be attributed to the factors such as the presence of key biopharmaceutical manufacturing facilities in the region, the rising number of drug development projects, the presence of a well-established healthcare market, significant spending on R&D activities, and the presence of a well-established intellectual property system for innovative biologics.

Key Market Players

Key players in the Pharmaceutical Filtration Market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Product, Technique, Type, Application, Scale of operation, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Companies covered

Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company, Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), and Membrane Solutions (US)

This report categorizes the pharmaceutical filtration market into the following segments and subsegments:

Pharmaceutical Filtration Market, by Product

  • Filters
  • Systems
  • Other Filtration Products

Pharmaceutical Filtration Market, by Filters

  • Membrane Filters
    • Polyethersulfone (PES)
    • Polyvinylidene Difluoride (PVDF)
    • Nylon
    • Polyetrafluoroethylene (PTFE)
    • Mixed Cellulose Ester & Cellulose Acetate (MCE & CA)
    • Polycarbonate Tracked Etched (PCTE)
    • Other Materials ( polypropylene (PP), cellulose nitrate (CN), regenerated cellulose (RC), gelatin, PETE, and Polyvinylchloride (PVC))
  • Depth Filters
    • Diatomaceous Earth
    • Cellulose
    • Activated Carbon
    • Perlite
    • Other Depth Filter Media (glass fibers, quartz, borosilicate, and resin binders)
  • Other Filters ( prefilters, bag filters, and magnetic filters)

Pharmaceutical Filtration Market, by Systems

  • Single Use
  • Reusable

Pharmaceutical Filtration Market, by Other Filtration Products

  • Filtration Assemblies
  • Filter Holders
  • Filtration Accessories

Pharmaceutical Filtration Market, by Technique

  • Microfiltration
  • Ultrafiltration
  • Nanofiltration
  • Other Techniques (Reverse osmosis and Ion exchange)

Pharmaceutical Filtration Market, by Type

Pharmaceutical Filtration Market, by Application

  • Pharmaceutical Filtration Market, by Final Product Processing
    • Active Pharmaceutical Ingredient (API) Filtration
    • Protein Purification
    • Vaccine and Antibody Processing
    • Formulation and Filling Solutions
    • Viral Clearance
  • Pharmaceutical Filtration Market, by Raw Material Filtration
    • Media Buffer Filtration
    • Prefiltration
    • Bioburden Testing
  • Cell Separation
  • Water Purification
  • Air Purification

Pharmaceutical Filtration Market, by End Scale of Operation

  • Manufacturing Scale
  • Pilot Scale
  • R&D Scale

Pharmaceutical Filtration Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
    • Brazil
    • RoLATAM
  • Middle East and Africa (MEA)

Recent Developments

  • In March 2021, Danaher (US) acquired Pall-Austar Lifesciences Limited to expand their manufacturing capacity for single-use technology supply chain demand in China.
  • In December 2020, Sartorius AG (Germany) acquired Watersep, which manufactures hollow‑fiber membrane devices and pre-sterilized assemblies for upstream and downstream biopharmaceutical applications. This acquisition will build the process filtration portfolio of Sartorius.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 56)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 62)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES BY RESPONDENT, DESIGNATION, AND REGION: PHARMACEUTICAL FILTRATION MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 3 PHARMACEUTICAL FILTRATION MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2021
           FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
    2.3 MARKET GROWTH RATE PROJECTIONS
           FIGURE 6 PHARMACEUTICAL FILTRATION MARKET (SUPPLY SIDE): CAGR PROJECTIONS
           FIGURE 7 PHARMACEUTICAL FILTRATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND SIDE FACTORS
           2.3.1 DATA TRIANGULATION
                    FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
           2.4.1 COVID-19 ASSUMPTIONS
    2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 74)
    FIGURE 9 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL FILTRATION MARKET

4 PREMIUM INSIGHTS (Page No. - 79)
    4.1 PHARMACEUTICAL FILTRATION MARKET OVERVIEW
           FIGURE 15 GROWING BIOPHARMACEUTICAL INDUSTRY AND INCREASING R&D SPENDING IN PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE AND COUNTRY (2021)
           FIGURE 16 FILTERS SEGMENT TO POSSESS LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL FILTRATION MARKET IN 2021
    4.3 PHARMACEUTICAL FILTRATION MARKET SHARE BY APPLICATION (2022 VS 2027)
                               FIGURE 17 FINAL PRODUCT PROCESSING APPLICATION SEGMENT TO DOMINATE MARKET IN 2027
    4.4 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2021 (USD MILLION)
           FIGURE 18 MICROFILTRATION SEGMENT TO DOMINATE MARKET IN 2021
    4.5 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2022 TO 2027

5 MARKET OVERVIEW (Page No. - 83)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 20 PHARMACEUTICAL FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           TABLE 1 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growth of biopharmaceutical industry to drive filtration products demand
                               TABLE 2 INDICATIVE LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS, 2020 AND 2021
                    5.2.1.2 Rising R&D spending in pharmaceutical & biotechnology industries to drive market growth
                               FIGURE 21 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
                    5.2.1.3 Increasing adoption of single-use technologies
                    5.2.1.4 New product launches by leading players support market growth
                    5.2.1.5 Increasing purity requirements in end user segments
           5.2.2 RESTRAINTS
                    5.2.2.1 Issues in membrane fouling to restrict market growth
                    5.2.2.2 High capital investment for new production facilities to limit entry of small players
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging economies offer lucrative growth opportunities
                    5.2.3.2 Advances in nanofiber technology to drive possibilities of nanofiltration
           5.2.4 CHALLENGES
                    5.2.4.1 Increased cost, reduced speed, and yield of filters to restrict market growth
                    5.2.4.2 Difficulty in small players and new entrants survival
    5.3 RANGES/SCENARIO
           FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PHARMACEUTICAL FILTRATION MARKET
    5.4 IMPACT OF COVID-19 ON PHARMACEUTICAL FILTRATION MARKET
           FIGURE 23 PHARMACEUTICAL FILTRATION MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021
    5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
           FIGURE 24 REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL FILTRATION PRODUCT PROVIDERS
    5.6 PRICING ANALYSIS
           TABLE 3 PRICE OF PHARMACEUTICAL FILTRATION PRODUCTS (2021)
    5.7 VALUE CHAIN ANALYSIS
                               FIGURE 25 VALUE CHAIN ANALYSIS OF PHARMACEUTICAL FILTRATION MARKET
    5.8 SUPPLY CHAIN ANALYSIS
           FIGURE 26 PHARMACEUTICAL FILTRATION MARKET: SUPPLY CHAIN ANALYSIS
    5.9 ECOSYSTEM ANALYSIS
           FIGURE 27 ECOSYSTEM ANALYSIS: PHARMACEUTICAL FILTRATION MARKET
           TABLE 4 SUPPLY CHAIN ECOSYSTEM
    5.10 PATENT ANALYSIS
           FIGURE 28 PATENT APPLICATIONS FOR PHARMACEUTICAL FILTRATION MARKET, JANUARY 2012–MARCH 2022
           TABLE 5 INDICATIVE LIST OF PATENTS IN PHARMACEUTICAL FILTRATION MARKET
    5.11 KEY CONFERENCES AND EVENTS IN 2022-2023
                    TABLE 6 PHARMACEUTICAL FILTRATION MARKET: LIST OF CONFERENCES AND EVENTS
    5.12 REGULATORY ANALYSIS
           5.12.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
           5.12.2 REGULATORY SCENARIO IN DIFFERENT REGION/COUNTRY
    5.13 PORTER’S FIVE FORCES ANALYSIS
                    TABLE 7 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF BUYERS
           5.13.4 BARGAINING POWER OF SUPPLIERS
           5.13.5 DEGREE OF COMPETITION
    5.14 KEY STAKEHOLDER AND BUYING CRITERIA
           5.14.1 KEY STAKEHOLDERS IN PHARMACEUTICAL COMPANIES AND THEIR INFLUENCE IN BUYING PROCESS
                    FIGURE 29 INFLUENCE OF PHARMACEUTICAL COMPANIES STAKEHOLDERS IN BUYING PROCESS OF PHARMACEUTICAL FILTRATION PRODUCTS
           5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL FILTRATION PRODUCTS AMONG END USERS
                    FIGURE 30 KEY BUYING CRITERIA FOR END USERS

6 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT (Page No. - 107)
    6.1 INTRODUCTION
           TABLE 8 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 FILTERS
           TABLE 9 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 10 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 11 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 12 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 13 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 14 GLOBAL PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
           6.2.1 MEMBRANE FILTERS
                    TABLE 15 GLOBAL PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 16 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 17 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 18 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 19 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 20 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                    6.2.1.1 Polyethersulfone (PES)
                               6.2.1.1.1 Wide application of hydrophilic pes membrane in sterilizing applications to drive market growth
                               TABLE 21 GLOBAL PES MEMBRANE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 22 NORTH AMERICA: PES MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 23 EUROPE: PES MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 24 ASIA PACIFIC: PES MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 25 LATIN AMERICA: PES MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.2 Polyvinylidene difluoride (PVDF)
                               6.2.1.2.1 FDA, USP, and EEC compliance to increase PVDF filters demand among end users
                               TABLE 26 GLOBAL PVDF MEMBRANE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 27 NORTH AMERICA: PVDF MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 28 EUROPE: PVDF MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 29 ASIA PACIFIC: PVDF MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 30 LATIN AMERICA: PVDF MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.3 Nylon
                               6.2.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive its demand in pharmaceutical applications
                               TABLE 31 GLOBAL NYLON MEMBRANE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 32 NORTH AMERICA: NYLON MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 33 EUROPE: NYLON MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 34 ASIA PACIFIC: NYLON MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 35 LATIN AMERICA: NYLON MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.4 POLYTETRAFLUOROETHYLENE (PTFE)
                               6.2.1.4.1 Wide use of PTFE membrane filters to retain ratings as fine as 0.01μ
                               TABLE 36 GLOBAL PTFE MEMBRANE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 37 NORTH AMERICA: PTFE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 38 EUROPE: PTFE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 39 ASIA PACIFIC: PTFE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 40 LATIN AMERICA: PTFE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA)
                               6.2.1.5.1 MCE membranes to possess wide application in analytical and research application
                               TABLE 41 GLOBAL MCE & CA MEMBRANE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 42 NORTH AMERICA: MCE & CA MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 43 EUROPE: MCE & CA MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 44 ASIA PACIFIC: MCE & CA MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 45 LATIN AMERICA: MCE & CA MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.6 POLYCARBONATE TRACK-ETCHED (PCTE)
                               6.2.1.6.1 PCTE membrane filters to be used in cell biology and analytical testing applications
                               TABLE 46 GLOBAL PCTE MEMBRANE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 47 NORTH AMERICA: PCTE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 48 EUROPE: PCTE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 49 ASIA PACIFIC: PCTE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 50 LATIN AMERICA: PCTE MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.7 Other materials
                               TABLE 51 GLOBAL OTHER MATERIAL MEMBRANE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 52 NORTH AMERICA: OTHER MATERIAL MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 53 EUROPE: OTHER MATERIAL MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 54 ASIA PACIFIC: OTHER MATERIAL MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 55 LATIN AMERICA: OTHER MATERIAL MEMBRANE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 DEPTH FILTERS
                    TABLE 56 GLOBAL DEPTH FILTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 57 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 58 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 59 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 60 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 61 DEPTH FILTRAS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                    6.2.2.1 Diatomaceous earth
                               6.2.2.1.1 Diatomaceous Earth to be used in-depth filters in biotechnology industry for cell clarification
                               TABLE 62 GLOBAL DIATOMACEOUS EARTH FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 63 NORTH AMERICA: DIATOMACEOUS EARTH FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 64 EUROPE: DIATOMACEOUS EARTH FILTER MARKET BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 65 ASIA PACIFIC: DIATOMACEOUS EARTH FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 66 LATIN AMERICA: DIATOMACEOUS EARTH FILTER MARKET BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.2.2 Cellulose
                               6.2.2.2.1 Cost-effectiveness of cellulose-based depth filter to drive market growth
                               TABLE 67 GLOBAL CELLULOSE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 68 NORTH AMERICA: CELLULOSE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 69 EUROPE: CELLULOSE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 70 ASIA PACIFIC: CELLULOSE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 71 LATIN AMERICA: CELLULOSE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.2.3 ACTIVATED CARBON
                               6.2.2.3.1 Reliable and economic activated carbon filters to be used in traditional pharmaceutical manufacturing operations
                               TABLE 72 GLOBAL ACTIVATED CARBON FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 73 NORTH AMERICA: ACTIVATED CARBON FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 74 EUROPE: ACTIVATED CARBON FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 75 ASIA PACIFIC: ACTIVATED CARBON FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 76 LATIN AMERICA: ACTIVATED CARBON FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.2.4 PERLITE
                               6.2.2.4.1 Perlite is lower in density to provide more purity than diatomaceous earth
                               TABLE 77 GLOBAL PERLITE FILTER MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 78 NORTH AMERICA: PERLITE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 79 EUROPE: PERLITE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 80 ASIA PACIFIC: PERLITE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 81 LATIN AMERICA: PERLITE FILTER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.2.5 OTHER DEPTH FILTER MEDIA
                               TABLE 82 GLOBAL OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 83 NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 84 EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 85 ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 86 LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.3 OTHER FILTERS
                    TABLE 87 GLOBAL OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 88 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 89 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 90 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 91 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 SYSTEMS
           TABLE 92 GLOBAL FILTRATION SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 93 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 94 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 95 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 96 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 97 GLOBAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
           6.3.1 SINGLE-USE SYSTEMS
                    6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost single-use systems adoption
                               TABLE 98 GLOBAL SINGLE-USE FILTRATION SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 99 NORTH AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 100 EUROPE: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 101 ASIA PACIFIC: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 102 LATIN AMERICA: SINGLE-USE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.2 REUSABLE SYSTEMS
                    6.3.2.1 Reusable systems to be used for large-scale manufacturing
                               TABLE 103 GLOBAL REUSEABLE SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 104 NORTH AMERICA: REUSEABLE SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 105 EUROPE: REUSEABLE SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 106 ASIA PACIFIC: REUSEABLE SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 107 LATIN AMERICA: REUSEABLE SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 OTHER FILTRATION PRODUCTS
           TABLE 108 OTHER FILTRATION PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
           TABLE 109 NORTH AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 110 EUROPE: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 111 ASIA PACIFIC: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 112 LATIN AMERICA: OTHER FILTRATION PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 113 OTHER FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
           6.4.1 FILTRATION ASSEMBLIES
                    6.4.1.1 FILTRATION ASSEMBLIES
                               TABLE 114 GLOBAL FILTRATION ASSEMBLIES MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 115 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 116 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 117 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 118 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.4.2 FILTER HOLDERS
                    6.4.2.1 Filter holders to provide structural support to membrane filters
                               TABLE 119 GLOBAL FILTER HOLDERS MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 120 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 121 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 122 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 123 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.4.3 FILTRATION ACCESSORIES
                    6.4.3.1 Increase in pharmaceutical filtration products adoption to support associated accessories used
                               TABLE 124 GLOBAL PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 125 NORTH AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 126 EUROPE: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 127 ASIA PACIFIC: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 128 LATIN AMERICA: PHARMACEUTICAL FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 PHARMACEUTICAL FILTRATION MARKET, TECHNIQUE (Page No. - 160)
    7.1 INTRODUCTION
           TABLE 129 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    7.2 MICROFILTRATION
           7.2.1 INCREASED ADOPTION OF MICROFILTRATION TECHNIQUE AND COST-EFFECTIVE NATURE TO PROPEL MARKET GROWTH
                    TABLE 130 GLOBAL MICROFILTRATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 131 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 132 EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 133 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 134 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 ULTRAFILTRATION
           7.3.1 ADOPTION OF FINE FILTRATION TECHNIQUE TO DRIVE MARKET GROWTH
                    TABLE 135 GLOBAL ULTRAFILTRATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 136 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 137 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 138 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 139 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 NANOFILTRATION
           7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH
                    TABLE 140 GLOBAL NANOFILTRATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 141 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 142 EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 143 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 144 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 OTHER TECHNIQUES
           7.5.1 HIGH PURITY WATER REQUIREMENT DURING BIOPHARMACEUTICAL MANUFACTURING TO INCREASE MARKET GROWTH
                    TABLE 145 GLOBAL OTHER TECHNIQUES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 146 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 147 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 148 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 149 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 PHARMACEUTICAL FILTRATION MARKET, BY TYPE (Page No. - 171)
    8.1 INTRODUCTION
           TABLE 150 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
    8.2 STERILE FILTRATION
           8.2.1 INCREASED MANUFACTURING OF BIOLOGICS DRUGS TO DRIVE STERILE FILTRATION DEMAND
                    TABLE 151 GLOBAL STERILE FILTRATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 152 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 153 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 154 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 155 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 NON-STERILE FILTRATION
           8.3.1 GROWTH OF R&D ACTIVITIES TO PROMOTE MARKET GROWTH
                    TABLE 156 GLOBAL NON-STERILE FILTRATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 157 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 158 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 159 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 160 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

9 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION (Page No. - 178)
    9.1 INTRODUCTION
           TABLE 161 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.2 FINAL PRODUCT PROCESSING
           TABLE 162 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2020–2027 (USD MILLION)
           TABLE 163 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 164 EUROPE PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, 2020–2027 (USD MILLION)
           TABLE 165 ASIA PACIFIC: PHARMACEUTICAL FILTERATION MARKET FOR FINAL PRODUCT PROCESSING, 2020–2027 (USD MILLION)
           TABLE 166 LATIN AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR FINAL PRODUCT PROCESSING, 2020–2027 (USD MILLION)
           TABLE 167 GLOBAL PHARMACEUTICAL FILTERS MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
           9.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION
                    9.2.1.1 Continuous filtration of API filtration to increase market growth
                               TABLE 168 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 169 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 170 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 171 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 172 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           9.2.2 PROTEIN PURIFICATION
                    9.2.2.1 Recent advancement in protein therapeutic drugs to propel market growth
                               TABLE 173 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 174 NORTH AMERICA PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 175 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 176 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 177 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
           9.2.3 VACCINE AND ANTIBODY PROCESSING
                    9.2.3.1 Rise in COVID-19 pandemic and other viral diseases to drive vaccine and antibody processing market
                               TABLE 178 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 179 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 180 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 181 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 182 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2020–2027 (USD MILLION)
           9.2.4 FORMULATION AND FILLING SOLUTIONS
                    9.2.4.1 Demand for aseptic filling and bioburden reduction to increase market growth
                               TABLE 183 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTION, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 184 NORTH AMERICA PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 185 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 186 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 187 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTION, BY COUNTRY, 2020–2027 (USD MILLION)
           9.2.5 VIRAL CLEARANCE
                    9.2.5.1 Growth in therapeutic monoclonal antibodies to increase market growth
                               TABLE 188 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 189 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 190 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 191 ASIA PACIFIC PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 192 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 RAW MATERIAL FILTRATION
           TABLE 193 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2020–2027 (USD MILLION)
           TABLE 194 NORTH AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 195 EUROPE PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, 2020–2027 (USD MILLION)
           TABLE 196 ASIA PACIFIC: PHARMACEUTICAL FILTERATION MARKET RAW MATERIAL FILTRATION, 2020–2027 (USD MILLION)
           TABLE 197 LATIN AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR RAW MATERIAL FILTRATION, 2020–2027 (USD MILLION)
           TABLE 198 GLOBAL PHARMACEUTICAL FILTERS MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
           9.3.1 MEDIA BUFFER FILTRATION
                    9.3.1.1 Growth in manufacturing of biopharmaceuticals to improve market growth
                               TABLE 199 GLOBAL PHARMACEUTICAL FILTERS MARKET FOR MEDIA BUFFER FILTRATION, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 200 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 201 EUROPE: PHARMACEUTICAL FILTERS MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 202 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 203 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET FOR MEDIA BUFFER FILTRATION, BY COUNTRY, 2020–2027 (USD MILLION)
           9.3.2 PREFILTRATION
                    9.3.2.1 Membrane fouling to increase market growth for prefilters
                               TABLE 204 GLOBAL PHARMACEUTICAL FILTERS MARKET FOR PREFILTRATION, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 205 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET FOR PREFILTARTION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 206 EUROPE: PHARMACEUTICAL FILTERS MARKET FOR PREFILTRATION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 207 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET FOR PREFILTARTION, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 208 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET FOR PREFILTARTION, BY COUNTRY, 2020–2027 (USD MILLION)
           9.3.3 BIOBURDEN TESTING
                    9.3.3.1 Strict quality control of biopharmaceuticals to improve market growth
                               TABLE 209 GLOBAL PHARMACEUTICAL FILTERS MARKET FOR BIOBURDEN TESTING, BY REGION, 2020–2027 (USD MILLION)
                               TABLE 210 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 211 EUROPE: PHARMACEUTICAL FILTERS MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 212 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
                               TABLE 213 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET FOR BIOBURDEN TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 CELL SEPARATION
           9.4.1 GROWTH IN PERSONALIZED MEDICINE TO IMPROVE MARKET GROWTH
                    TABLE 214 GLOBAL PHARMACEUTICAL FILTERATION MARKET FOR CELL SEPARATION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 215 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 216 EUROPE PHARMACEUTICAL FILTRATION MARKET FOR CELL SEPARATION, 2020–2027 (USD MILLION)
                    TABLE 217 ASIA PACIFIC: PHARMACEUTICAL FILTERATION MARKET FOR CELL SEPARATION, 2020–2027 (USD MILLION)
                    TABLE 218 LATIN AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR CELL SEPERATION, 2020–2027 (USD MILLION)
    9.5 WATER PURIFICATION
           9.5.1 GROWTH IN AGED POPULATION TO INCREASE MARKET GROWTH
                    TABLE 219 GLOBAL PHARMACEUTICAL FILTERATION MARKET FOR WATER PURIFICATION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 220 NORTH AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR WATER PURIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 221 EUROPE PHARMACEUTICAL FILTRATION MARKET FOR WATER PURIFICATION, 2020–2027 (USD MILLION)
                    TABLE 222 ASIA PACIFIC: PHARMACEUTICAL FILTERATION MARKET FOR WATER PURIFICATION, 2020–2027 (USD MILLION)
                    TABLE 223 LATIN AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR WATER PURIFICATION, 2020–2027 (USD MILLION)
    9.6 AIR PURIFICATION
           9.6.1 INCREASED ADOPTION OF GMP PRACTICES TO INCREASE MARET GROWTH
                    TABLE 224 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 225 NORTH AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR AIR PURIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 226 EUROPE PHARMACEUTICAL FILTRATION MARKET FOR AIR PURIFICATION, 2020–2027 (USD MILLION)
                    TABLE 227 ASIA PACIFIC: PHARMACEUTICAL FILTERATION MARKET FOR AIR PURIFICATION, 2020–2027 (USD MILLION)
                    TABLE 228 LATIN AMERICA: PHARMACEUTICAL FILTERATION MARKET FOR AIR PURIFICATION, 2020–2027 (USD MILLION)

10 PHARMACEUTICAL FILTRATION MARKET, SCALE OF OPERATION (Page No. - 210)
     10.1 INTRODUCTION
               TABLE 229 GLOBAL PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
     10.2 MANUFACTURING-SCALE OPERATION
             10.2.1 EXPANSION BY PHARMACEUTICALS TO MANUFACTURE COVID-19 DRUGS TO DRIVE MARKET GROWTH
                       TABLE 230 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY REGION, 2020–2027 (USD MILLION)
                       TABLE 231 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 232 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 233 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 234 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR MANUFACTURING-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
     10.3 PILOT-SCALE OPERATION
             10.3.1 INCREASED OUTSOURCING AND COST-EFFECTIVE NATURE TO PROMOTE MARKET GROWTH
                       TABLE 235 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY REGION, 2020–2027 (USD MILLION)
                       TABLE 236 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 237 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 238 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 239 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PILOT-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
     10.4 R&D-SCALE OF OPERATION
             10.4.1 EXPENDITURE FOR R&D OF BIOLOGICS TO INCREASE MARKET GROWTH
                       TABLE 240 GLOBAL PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY REGION, 2020–2027 (USD MILLION)
                       TABLE 241 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 242 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 243 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 244 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR R&D-SCALE OPERATION, BY COUNTRY, 2020–2027 (USD MILLION)

11 PHARMACEUTICAL FILTRATION MARKET, BY REGION (Page No. - 219)
     11.1 INTRODUCTION
               TABLE 245 PHARMACEUTICAL FILTRATION MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA
               FIGURE 31 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT
               TABLE 246 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
               TABLE 247 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
               TABLE 248 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 249 NORTH AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
               TABLE 250 NORTH AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
               TABLE 251 NORTH AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 252 NORTH AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 253 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
               TABLE 254 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 255 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
               TABLE 256 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 257 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 258 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.2.1 US
                       11.2.1.1 Ownership of patented manufacturing and investment in R&D to drive market growth
                                   FIGURE 32 US TO DOMINATE DISTRIBUTION OF R&D COMPANIES BY REGION (2020 VS. 2019)
                                   TABLE 259 US: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 260 US: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 261 US: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 262 US: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 263 US: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 264 US: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 265 US: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 266 US: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 267 US: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 268 US: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 269 US: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
            TABLE 270 US: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.2.2 CANADA
                       11.2.2.1 Increased pharmaceutical drugs sale to support market growth
                                   TABLE 271 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 272 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 273 CANADA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 274 CANADA: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 275 CANADA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 276 CANADA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 277 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 278 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 279 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 280 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 281 CANADA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 282 CANADA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
     11.3 EUROPE
               TABLE 283 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
               TABLE 284 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
               TABLE 285 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 286 EUROPE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
               TABLE 287 EUROPE: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
               TABLE 288 EUROPE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 289 EUROPE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 290 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
               TABLE 291 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 292 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
               TABLE 293 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 294 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 295 EUROPE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.3.1 GERMANY
                       11.3.1.1 Growing biosimilar market in Germany to drive market growth
                                   TABLE 296 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 297 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 298 GERMANY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 299 GERMANY: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 300 GERMANY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 301 GERMANY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 302 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 303 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 304 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 305 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 306 GERMANY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
            TABLE 307 GERMANY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.3.2 UK
                       11.3.2.1 Increased R&D investment and government aid to boost market growth
                                   TABLE 308 UK: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 309 UK: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 310 UK: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 311 UK: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 312 UK: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 313 UK: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 314 UK: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 315 UK: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 316 UK: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 317 UK: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 318 UK: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 319 UK: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.3.3 FRANCE
                       11.3.3.1 Foreign investment in pharmaceutical market to drive growth
                                   TABLE 320 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 321 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 322 FRANCE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 323 FRANCE: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 324 FRANCE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 325 FRANCE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 326 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 327 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 328 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 329 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 330 FRANCE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 331 FRANCE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.3.4 ITALY
                       11.3.4.1 Investment in R&D for biotech industry to boost market growth
                                   TABLE 332 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 333 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 334 ITALY: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 335 ITALY: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 336 ITALY: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 337 ITALY: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 338 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 339 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 340 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 341 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 342 ITALY: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 343 ITALY: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.3.5 SPAIN
                       11.3.5.1 Expansion of biomanufacturing facilities to support market growth
                                   TABLE 344 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 345 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 346 SPAIN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 347 SPAIN: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 348 SPAIN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 349 SPAIN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 350 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 351 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 352 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 353 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 354 SPAIN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 355 SPAIN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.3.6 REST OF EUROPE
                       TABLE 356 ROE: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                       TABLE 357 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 358 ROE: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                       TABLE 359 ROE: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                       TABLE 360 ROE: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 361 ROE: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 362 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 363 ROE: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 364 ROE: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                       TABLE 365 ROE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 366 ROE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 367 ROE: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
     11.4 ASIA PACIFIC
               FIGURE 33 APAC: PHARMACEUTICAL FILTRATION MARKET SNAPSHOT
               TABLE 368 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
               TABLE 369 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
               TABLE 370 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 371 ASIA PACIFIC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
               TABLE 372 ASIA PACIFIC: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
               TABLE 373 ASIA PACIFIC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 374 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 375 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
               TABLE 376 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 377 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
               TABLE 378 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 379 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 380 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
               11.4.1 CHINA
                       11.4.1.1 Shift from generic medicine to innovative drugs to drive market for advanced pharmaceutical filtration
                                   TABLE 381 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 382 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 383 CHINA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 384 CHINA: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 385 CHINA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 386 CHINA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 387 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 388 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 389 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 390 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 391 CHINA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 392 CHINA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.4.2 JAPAN
                       11.4.2.1 Strict regulatory guidelines to create need for advanced filtration device
                                   TABLE 393 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 394 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 395 JAPAN: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 396 JAPAN: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 397 JAPAN: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 398 JAPAN: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 399 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 400 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 401 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 402 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 403 JAPAN: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 404 JAPAN: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.4.3 INDIA
                       11.4.3.1 Government initiatives and competitive nature of the Indian pharmaceutical market to display market growth for filtration
                                   TABLE 405 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 406 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 407 INDIA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 408 INDIA: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 409 INDIA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 410 INDIA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
FALSE
                                   TABLE 412 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 413 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 414 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 415 INDIA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 416 INDIA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.4.4 SOUTH KOREA
                       11.4.4.1 Increased export of drugs to affect market growth
                                   TABLE 417 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 418 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 419 SOUTH KOREA: MEMBRANE FILTER MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 420 SOUTH KOREA: DEPTH FILTER MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 421 SOUTH KOREA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 422 SOUTH KOREA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 423 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 424 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 425 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 426 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 427 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 428 SOUTH KOREA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.4.5 REST OF ASIA PACIFIC
                       TABLE 429 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                       TABLE 430 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 431 ROAPAC: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                       TABLE 432 ROAPAC: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                       TABLE 433 ROAPAC: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 434 ROAPAC: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 435 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 436 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 437 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                       TABLE 438 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 439 ROAPAC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 440 ROAPAC: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
     11.5 LATIN AMERICA
               TABLE 441 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
               TABLE 442 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
               TABLE 443 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 444 LATIN AMERICA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
               TABLE 445 LATIN AMERICA: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
               TABLE 446 LATIN AMERICA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 447 LATIN AMERICA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 448 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
               TABLE 449 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 450 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
               TABLE 451 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 452 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
               TABLE 453 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.5.1 BRAZIL
                       11.5.1.1 Growth of vaccine manufacturing to increase market growth
                                   TABLE 454 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                   TABLE 455 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 456 BRAZIL: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                                   TABLE 457 BRAZIL: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                                   TABLE 458 BRAZIL: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 459 BRAZIL: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 460 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 461 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 462 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                   TABLE 463 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 464 BRAZIL: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                                   TABLE 465 BRAZIL: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
             11.5.2 REST OF LATIN AMERICA
                       TABLE 466 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                       TABLE 467 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 468 ROLATAM: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                       TABLE 469 ROLATAM: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                       TABLE 470 ROLATAM: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 471 ROLATAM: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 472 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 473 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 474 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                       TABLE 475 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 476 ROLATAM: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 477 ROLATAM: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA (MEA)
             11.6.1 SLOW AND EVOLVING BIOPHARMACEUTICAL INDUSTRY AND REGULATIONS TO HAMPER MARKET GROWTH
                       TABLE 478 MEA: PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                       TABLE 479 MEA: PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 480 MEA: MEMBRANE FILTERS MARKET, BY MATERIAL, 2020–2027 (USD MILLION)
                       TABLE 481 MEA: DEPTH FILTERS MARKET, BY MEDIA, 2020–2027 (USD MILLION)
                       TABLE 482 MEA: PHARMACEUTICAL FILTRATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 483 MEA: OTHER PHARMACEUTICAL FILTRATION PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 484 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 485 MEA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 486 MEA: PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                       TABLE 487 MEA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 488 MEA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 489 MEA: PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION, 2020–2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 317)
                       12.1 INTRODUCTION
     12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
               FIGURE 34 PHARMACEUTICAL FILTRATION MARKET: STRATEGIES ADOPTED
     12.3 MARKET SHARE ANALYSIS
               FIGURE 35 PHARMACEUTICAL FILTRATION SERVICES MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2021)
               TABLE 490 PHARMACEUTICAL FILTRATION MARKET: DEGREE OF COMPETITION
     12.4 REVENUE ANALYSIS
               FIGURE 36 REVENUE ANALYSIS FOR KEY COMPANIES (2019-2021)
     12.5 COMPANY EVALUATION QUADRANT
               FIGURE 37 PHARMACEUTICAL FILTRATION SERVICES MARKET: C OMPANY EVALUATION MATRIX, 2021
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
     12.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
             12.6.1 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
                       TABLE 491 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
             12.6.2 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
                       TABLE 492 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
             12.6.3 COMPANY TECHNIQUE OFFERING FOOTPRINT (25 COMPANIES)
                       TABLE 493 TECHNIQUE OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
             12.6.4 COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
                       TABLE 494 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL FILTRATION MARKET
     12.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
               FIGURE 38 PHARMACEUTICAL FILTRATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021
             12.7.1 PROGRESSIVE COMPANIES
             12.7.2 STARTING BLOCKS
             12.7.3 RESPONSIVE COMPANIES
             12.7.4 DYNAMIC COMPANIES
                       12.7.4.1 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
                                   TABLE 495 PHARMACEUTICAL FILTRATION MARKET: DETAILED LIST OF KEY STARTUP/SMES
                                   TABLE 496 PHARMACEUTICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES]
     12.8 COMPETITIVE SCENARIO AND TRENDS
             12.8.1 PRODUCT LAUNCHES
                       TABLE 497 PHARMACEUTICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019- MARCH 2022
             12.8.2 DEALS
                       TABLE 498 PHARMACEUTICAL FILTRATION MARKET: DEALS, JANUARY 2019-MARCH 2022
             12.8.3 EXPANSION
                       TABLE 499 PHARMACEUTICAL FILTRATION MARKET: EXPANSION, JANUARY 2019-MARCH 2022

13 COMPANY PROFILES (Page No. - 336)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     13.1 KEY PLAYERS
             13.1.1 MERK KGAA
                       TABLE 500 MERCK KGAA: BUSINESS OVERVIEW
                       FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2021)
             13.1.2 DANAHER CORPORATION
                       TABLE 501 DANAHER CORPORATION: BUSINESS OVERVIEW
                       FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.3 SARTORIUS AG
                       TABLE 502 SARTORIUS AG: BUSINESS OVERVIEW
                       FIGURE 41 SARTORIUS AG: COMPANY SNAPSHOT (2021)
             13.1.4 PARKER-HANNIFIN CORPORATION
                       TABLE 503 PARKER-HANNIFIN CORPORATION: BUSINESS OVERVIEW
                       FIGURE 42 PARKER-HANNIFIN CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.5 EATON CORPORATION PLC
                       TABLE 504 EATON CORPORATION PLC: BUSINESS OVERVIEW
                       FIGURE 43 EATON CORPORATION PLC: COMPANY SNAPSHOT (2021)
             13.1.6 THERMO FISHER SCIENTIFIC INC.
                       TABLE 505 THERMO FISHER SCIENTIFIC INC: BUSINESS OVERVIEW
                       FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2021)
             13.1.7 3M COMPANY
                       TABLE 506 3M COMPANY: BUSINESS OVERVIEW
                       FIGURE 45 3M COMPANY: COMPANY SNAPSHOT (2021)
             13.1.8 DONALDSON COMPANY, INC.
                       TABLE 507 DONALDSON COMPANY, INC.: BUSINESS OVERVIEW
                       FIGURE 46 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT (2021)
             13.1.9 REPLIGEN CORPORATION
                       TABLE 508 REPLIGEN CORPORATION: BUSINESS OVERVIEW
                       FIGURE 47 REPLIGEN CORPORATION.: COMPANY SNAPSHOT (2021)
             13.1.10 PORVAIR PLC
                       TABLE 509 PORVAIR PLC: BUSINESS OVERVIEW
                       FIGURE 48 PORVAIR PLC: COMPANY SNAPSHOT (2021)
             13.1.11 ALFA LAVAL CORPORATE AB
                       TABLE 510 ALFA LAVAL CORPORATE AB: BUSINESS OVERVIEW
                       FIGURE 49 ALFA LAVAL CORPORATE AB: COMPANY SNAPSHOT (2021)
             13.1.12 CORNING INCORPORATED
                       TABLE 511 CORNING INCORPORATED: BUSINESS OVERVIEW
                       FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2021)
             13.1.13 MEISSNER FILTRATION PRODUCTS, INC.
                       TABLE 512 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
             13.1.14 AMAZON FILTERS LTD.
                       TABLE 513 AMAZON FILTERS LTD.: BUSINESS OVERVIEW
             13.1.15 GRAVER TECHNOLOGIES, LLC.
                       TABLE 514 GRAVER TECHNOLOGIES, LLC.: BUSINESS OVERVIEW
     13.2 OTHER COMPANIES
             13.2.1 MMS AG
             13.2.2 MANN+HUMMEL INTERNATIONAL GMBH & CO. KG
             13.2.3 ERTELALSOP
             13.2.4 KASAG SWISS AG
             13.2.5 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG
             13.2.6 COLE-PARMER INSTRUMENT COMPANY, LCC.
             13.2.7 CANTEL MEDICALCORP.
             13.2.8 FILTROX AG
             13.2.9 SAINT-GOBAIN PERFORMANCE PLASTICS
             13.2.10 MEMBRANE SOLUTIONS

*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 409)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global pharmaceutical filtration market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as American Membrane Technology Associations (AMTA), European Membrane Society (EMS), American Association of Pharmaceutical Scientists (AAPS), Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), Parenteral Drug Association (PDA), Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada, National Institutes of Health (NIH), World Health Organisation (WHO), Indian Pharmaceutical Association (IPA), International Society for Pharmaceutical Engineering (ISPE), BioProcess International Magazine, BioPharm International, Journal of Bioprocessing and Biotechniques, BioPlan Associates, ScienceDirect, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Analysis, Corporate Presentations, Expert Interviews, and MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global pharmaceutical filtration market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global pharmaceutical filtration market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including North America, Europe, the Asia Pacific, and the Rest of the World. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Pharmaceutical Filtration Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the pharmaceutical filtration market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of pharmaceutical filtration market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the pharmaceutical filtration business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Objectives

  • To define, describe, and forecast the pharmaceutical filtration market by product, technique, type, application, scale of operation, and region
  • To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their market shares and core competencies in the global pharmaceutical filtration market
  • To track and analyze competitive developments such as product & service launches, partnerships, collaborations, agreements, expansions, and acquisitions in the global pharmaceutical filtration market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographical Analysis

  • Further breakdown of the RoE pharmaceutical filtration market, by country
  • Further breakdown of the RoAPAC pharmaceutical filtration market, by country
  • Further breakdown of the RoLA and MEA pharmaceutical filtration markets, by country

Company Information

  • Detailed analysis and profiling of additional market players (Up to five)

Segment Analysis

  • Further breakdown of the therapeutic area segment as per the service portfolio of prominent players operating in the market.
Pharmaceutical Filtration Market Size,  Share & Growth Report
Report Code
BT 4058
Published ON
Mar, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status